ISRCTN23255677
Completed
Not Applicable
Deep brain stimulation (DBS) of the nucleus accumbens in treatment-refractory patients with obsessive-compulsive disorder (OCD)
Academic Medical Center (AMC) (The Netherlands)0 sites16 target enrollmentJune 7, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obsessive-compulsive disorder (OCD)
- Sponsor
- Academic Medical Center (AMC) (The Netherlands)
- Enrollment
- 16
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Primary diagnosis: OCD (300\.3\) according to Diagnostic and Statistical Manual of Mental Disorders \- Fourth Edition (DSM\-IV) criteria using the mini\-international neuropsychiatric interview (MINI) plus interview as a diagnostic instrument
- •2\. Illness duration \>5 years
- •3\. Yale\-Brown obsessive\-compulsive scale (Y\-BOCS) total \>27, measured twice at least two weeks apart
- •4\. Disabling severity with substantial functional impairment according to the DSM\-IV criterion C and a global assessment of function (GAF) score of \<45
- •5\. Age 18 \- 65 years
- •6\. Written informed consent
- •7\. Able to fully understand the consequences of the procedure (intelligence quotient \[IQ] \>80\)
- •8\. Dutch speaking and able to answer all study questions
- •9\. Capable to make his or her own choice without coercion
- •10\. Treatment refractory is defined as no response or insufficient response (still fulfilling the inclusion criteria) following:
Exclusion Criteria
- •Any of the following unstable physical conditions: Parkinson's disease, dementia, epilepsy, schizophrenia or history of psychosis, alcohol or substance abuse during last 6 months, current tic disorder, antisocial personality disorder, body dismorphic disorder, pregnancy, use of psychiatric medication other than stable use of one SSRI or clomipramine, one benzodiazepine, one atypical antipsychotic.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Deep brain stimulation (DBS) of the nucleus accumbens in treatment-refractory patients with obsessive-compulsive disorder (OCD).Obsessive-compulsive disorder (OCD)NL-OMON20428Implantation equipment is provided by Medtronic Europe, Tolochenaz, Switzerland.No personal funding of research personell.16
Recruiting
Phase 2
Deep Brain Stimulation for Treatment of Obsessive-Compulsive DisorderIRCT20161026030510N2Iran University of Medical Sciences5
Active, not recruiting
Not Applicable
Effects of deep brain stimulation of the nucleus accumbens on the dopaminergic activity in patients with Gilles-de-la-Tourette-syndromeThe participants under study are recruited from a sample of patients suffering from a severe form of the Gilles-de-la-Tourette-syndrome who are waiting to receive deep-brain stimulation of the ncl. accumbens as therapeutic treatment.EUCTR2006-005567-26-DEniversity of Aachen
Withdrawn
Not Applicable
Deep Brain Stimulation of the Nucleus Basalis of Meynert in patients with Parkinson's DiseaseParkinson'sParkinson's disease1002803710012272NL-OMON45897niversitair Medisch Centrum Groningen11
Recruiting
Not Applicable
Influence of deep brain stimulation of the nucleus subthalamicus on motor adaptation in subjects with Parkinson's diseaseG20.1DRKS00031514niversitätsklinikum Leipzig, Neurologie50